drugset / Trial / NCT01138826
Bioavailability Study Comparing 10 Mg Amlodipine Besylate Orally Disintegrating Tablet (ODT) And 10 Mg Amlodipine Besylate Tablets
Phase 1
Completed
18 enrolled
Viatris Inc.
Aurobindo Pharma Ltd · collabTrident Life Sciences Ltd. · collab
RandomizedCrossoverOpen-labelBasic science
Summary
This study is being performed to determine the bioavailability, or extent of absorption into the body, of a 10 mg amlodipine besylate orally disintegrating tablet (ODT) as compared to the bioavailability of a 10 mg amlodipine besylate (non-ODT) tablet.
Timeline
- Start
- 2010-05
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 10 mg | Oral |
Indications
No indication recorded.